Inspirion Wealth Advisors LLC Reduces Stake in HealthEquity, Inc. (NASDAQ:HQY)

Inspirion Wealth Advisors LLC cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 13.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 65,000 shares of the company's stock after selling 10,005 shares during the quarter. HealthEquity accounts for approximately 0.8% of Inspirion Wealth Advisors LLC's holdings, making the stock its 20th biggest holding. Inspirion Wealth Advisors LLC owned approximately 0.08% of HealthEquity worth $5,744,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity during the fourth quarter valued at about $26,000. Versant Capital Management Inc bought a new position in shares of HealthEquity in the 1st quarter worth approximately $28,000. Transce3nd LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at approximately $29,000. Smartleaf Asset Management LLC boosted its position in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC purchased a new stake in HealthEquity in the fourth quarter worth $39,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 1.9%

Shares of HealthEquity stock traded up $2.11 on Thursday, reaching $115.17. The company had a trading volume of 813,926 shares, compared to its average volume of 819,973. The firm's 50-day moving average price is $90.51 and its two-hundred day moving average price is $97.67. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $116.69. The firm has a market cap of $9.96 billion, a price-to-earnings ratio of 105.66, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the firm earned $0.80 earnings per share. As a group, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now directly owns 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on HQY shares. Royal Bank of Canada lifted their target price on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft raised their price target on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday. Bank of America upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday. The Goldman Sachs Group raised their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research note on Wednesday. Finally, JMP Securities lifted their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday. One research analyst has rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $116.91.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.